Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 24.70
+0.35 (1.44%)
Mar 6, 2026, 1:30 PM CST
Orient Pharma Company Description
Orient Pharma Co., Ltd. engages in the development of new drugs in Taiwan and internationally.
It offers cardiovascular drugs, such as Pitator and Tonvasca for lipid suppression, as well as Zulitor, a lipid lowering drug; psychotropic drugs, including Trokendi XR extended, Methydur, and powder and solvent for prolonged-release suspension for injection.
The company was founded in 2008 and is based in Taipei, Taiwan.
Orient Pharma Co., Ltd.
| Country | Taiwan |
| Founded | 2008 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 173 |
| CEO | Chun-Tong Huang |
Contact Details
Address: Central Science Park Taipei, 106 Taiwan | |
| Phone | 886 2 2325 7621 |
| Website | oppharma.com |
Stock Details
| Ticker Symbol | 4166 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004166004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chun-Tong Huang | General Manager |
| Yi Xin Zhang | Chief Financial Officer |
| Zhi Cheng Lu | Chief Operating Officer |
| Mei Xiu Han | Accounting Supervisor |